In contrast to its macrophage-activating capacity, IFN-'y downregulates expression of the macrophage mannose receptor (MMR), which mediates uptake ofCandida and other microorganisms. We found that IFN-"y induced a concentration-dependent increase in the capacity ofhuman monocyte-derived macrophages to ingest and kill both opsonized and unopsonized Candida albicans and to release superoxide anion upon stimulation with Candida. Mannan or mannosylated albumin inhibited this activated uptake of unopsonized Candida, but glucan did not. Addition of mAb to complement receptor (CR) 3 did not inhibit ingestion; macrophages that lacked CR3 (leukocyte adhesion defect) showed normal upregulation of ingestion by IFN-,y. The Invest. 1993Invest. . 91:2596Invest. -2601
Introduction
Candida albicans is an increasingly important opportunistic pathogen in immunocompromised patients, but mechanisms ofhost defense against Candida are not completely understood ( 1) . Experimental evidence suggests that mononuclear phagocytes could play an important role in eradication of Candida and that full expression of candidacidal functions may require stimulation by activating agents (2) (3) (4) (5) (6) . IFN--y has been the best-studied of the macrophage-activating cytokines (7) .
Macrophages express on their surface a 175-kD cell lineage-specific glycoprotein receptor that binds and internalizes both soluble and particulate ligands with terminal mannose residues (8) (9) (10) (11) (12) (13) . We have found that human monocyte-derived macrophages (macrophages) phagocytose unopsonized Candida primarily through this macrophage mannose receptor (MMR)' (4) . In addition to the Candida species, the human MMR has been implicated in the uptake of other microorganisms, including Pseudomonas ( 11 ), Pneumocystis carinii ( 12) , Leishmania donovani (13) , and the Mycobacterium avium complex ( 14, 15) . Expression ofthe MMR is highly susceptible to downregulation by macrophage-activating agents (16) (17) (18) , an unexpected effect in view of the enhanced microbicidal capacity of activated macrophages.
This study was undertaken to investigate the effect of activation by IFN-y on macrophage anticandidal functions. We report here that treatment of human macrophages with IFN-y enhanced the capacity of these cells to ingest and kill C. albicans, as well as to release superoxide anion (O -) and exhibit an increase in intracellular free Ca2+ ([Ca2+] i) upon stimulation with Candida. Both the rate and extent ofmannose-inhibitable uptake of unopsonized Candida were increased in spite of a marked downregulation ofthe binding and pinocytic uptake of 1251-labeled mannose-BSA.
Methods
Monoclonal antibodies. mAb OKM 1 (IgG2b) is directed against the lectin-like binding site of the a-chain of complement receptor (CR) 3 as described ( 19, 20) . mAb Ml /70 (IgG2b; Boehringer Mannheim Corp., Indianapolis, IN) blocks binding sites for both iC3b and sugars on the a subunit of CR3 (19) . The assays used saturating concentrations of mAbs determined by flow cytometry. Monocyte-derived macrophages. Mononuclear cells were separated from the blood of normal adults using lymphocyte separation medium (Organon Teknika, Rockville, MD) and cultured in suspension with autologous serum and antibiotics for 3-5 d as described (4) . In some experiments preparations were further enriched for monocytes using density centrifugation with Nycodenz monocytes (Nycomed, Oslo, Norway) (4, 21 ) . All materials used to separate, culture, or assay macrophages were free of detectable endotoxin using the Limulus amebocyte lysate kit (Associates of Cape Cod, Woods Hole, MA) (4).
Treatment ofmacrophages with IFN-,y. Human rIFN--y was generously provided by Dr. Susan Kramer (Genentech, South San Fran-cisco, CA). At the concentrations indicated, IFN-y was added to macrophages after 72 h of culture, and incubation was continued for an additional 48 h. Equivalent amounts of DME (GIBCO BRL, Gaithersburg, MD) were added as control.
Phagocytosis and binding assays. Phagocytosis of C. albicans (ATCC 18804, maintained and prepared as described [4] ) was determined by incubating an equal number of macrophages and Candida for 60 min at 370C under continuous rotation (4 rpm) (4) . At various times, 50-pu aliquots of the mixture were removed to make cytospin preparations. These were stained with Diff-Quick (Baxter Healthcare Corp., Deerfield, IL) and the percentage of ingested yeast was determined (4). Candida yeasts within detectable phagocytic vacuoles were considered intracellular (4). Phagocytosis was also studied using yeasts conjugated with FITC (Sigma Chemical Co., St. Louis, MO) (4, 22) . Fluorescence of Candida not fully ingested was extinguished by addition of 0.5 mg/ml crystal violet (3, 22) .
Binding of Candida to macrophages was defined as a close association between -25% or more ofthe circumference ofthe yeast particle and the macrophage plasma membrane. Each experiment counted binding to macrophages in 200 high-power fields.
Candidacidal assay. Candida were mixed with a mononuclear cell suspension at a 1:1 ratio of Candida to macrophages and incubated for 60 min at 370C under rotation (4 rpm) (23) . At various time points, 0.1-ml aliquots were removed and the cells were disrupted by freezing and thawing, vortexed vigorously for 10 s, diluted, and plated for colony counting (23) . The freeze-thaw did not affect viability ofthe Candida (23) .
Measurement ofrelease ofO2. Release of°2 by macrophages was measured as the SOD-inhibitable reduction of ferricytochrome c (23) . Equal numbers of macrophages and Candida were incubated under rotation (4 rpm).
Iodination ofmannosylated BSA. Mannosylated BSA (Man-BSA; E-Y Laboratories, Inc., San Mateo, CA) was radiolabeled with Na'25I
by the chloramine T method (24) . Free iodine was removed by separation with Sephadex G-25 chromatography. 0.4-ml samples were collected and active fractions were identified by gamma counting. Protein was quantitated as described by Miller (25) , and specific activity was typically 5-8 x 106 cpm/jgg of Man-BSA protein, with > 95% of total counts being TCA precipitable. The preparation was used within 2 wk of iodination. Determination ofbinding and uptake of'25I-Man-BSA by normal and IFN-y-treated macrophages. Teflon beakers containing macrophages cultured with or without IFN-'y were cooled in an ice bath for 30 min. The cell suspensions were transferred to 50-ml polypropylene centrifuge tubes on ice, washed twice, and suspended in HBSS containing 10% HSA (pH 7. 1; Cutter, Emeryville, CA). After addition of 125I-Man-BSA (final concentration, 20 ,g protein/ml) the incubation mixture containing 5 X I05 macrophages (0.4 ml) was layered onto I ml of a gradient of four parts Coming 702 oil (Fisher Scientific Co., Pittsburgh, PA) and one part Apiezon oil (Apiezon, London, UK) and incubated for 10 min at 0°C for binding assays or 37°C for pinocytosis. After incubation the cells were immediately centrifuged (4°C, 10 min, 16,000 g) to separate cell-associated from unbound ligands. The oil was then frozen in dry ice-ethanol, and the cell-bound gamma radioactivity was measured in the cut pellet. Nonspecific binding or uptake, determined in the presence of 2 mg/ ml mannan (Sigma Chemical Co.), was < 15% and was subtracted from the total counts per minute to determine specific binding or uptake (26) . All determinations were carried out in duplicate. K~p was calculated by graphical estimation from the double reciprocal plot (26) .
Measurement of [Ca2+1i. Suspensions of macrophages were treated with fura-2 AM (4, 27, 28), centrifuged at 200 g for 5 min, and resuspended at a concentration of 107 macrophages/ml in KrebsRinger phosphate buffer with dextrose (KRPD). Immediately before use, a 0.5-ml cell suspension was centrifuged and the cells were resuspended in 2 ml of 37°C buffer and added to a heated (37°C) cuvette in which they were stirred continuously. Candida (107 in 50 Mi buffer)
were added to begin the reaction, and fluorescence changes were monitored. Changes in fluorescence intensity caused by Candida alone were subtracted from those obtained with phagocytes stimulated with Candida (4).
Expression ofdata. Results are expressed as mean±SEM. n refers to the number ofexperiments, each done in duplicate or triplicate. Statistical significance was determined by t test or analysis of variance (AN-OVA), as indicated.
Results
Effects ofIFN-y on phagocytic uptake ofCandida and release ofO2. Preincubation of macrophages with IFN-,y for 48 h induced a concentration-dependent increase in the uptake ofunopsonized C. albicans and in C. albicans-stimulated release of O2 (Fig. 1) . Maximal activity for both functions occurred at a concentration of 100 U/ml, with no appreciable increase being achieved by treatment of cells with 200 U/ml (Fig. 1) or 500 U/ml (n = 7; not shown).
The time course of phagocytic uptake and release of O2 after incubation of macrophages with 100 U/ml IFN-y or buffer alone is shown in Fig. 2 Fig. 2, left) .
We compared the phagocytosis of fully opsonized C. albicans (2.5% fresh human serum) (4) by resident and IFN-'ytreated macrophages. Phagocytosis was more rapid than that with unopsonized Candida, as shown previou phagocytic uptake of opsonized Candida by macrophages after 10 min of incubation was 64:
lum, compared with 38±9% by resident macrop was 89±9 and 61±7%, respectively, after 20 min (n = 5-6, P < 0.01 at both time points).
Effect ofIFN-'y on macrophage candidacida increased phagocytic activity and 0°release of macrophages were accompanied by an enhance these cells to kill the ingested, unopsonized fungi rophages treated with 100 U/ml IFN--y killed times more C. albicans than did untreated cells time points studied (Fig. 3 , P < 0.001, ANOVA
Evidence that the enhanced phagocytosis o IFN-'y-treated macrophages is mediated by bindi MMR. Human macrophages phagocytose unoi dida species primarily through the mannose rec investigated the involvement of mannose recept take of unopsonized C. albicans by macrophl with IFN-,y by studying phagocytosis in the pi sence of mannan, Man-BSA, or glucan. Both Man-BSA inhibited uptake of Candida in a con( pendent fashion; slight but insignificant inhibitic could be detected at a high concentration of glue These findings are equivalent to those with req phages (4), suggesting that ingestion in IFN-y-t phages also depends primarily on binding and u the mannose receptor. 
IFN-y-treated
Monocyte-derived macrophages from two patients with ±7% of inoculeukocyte adhesion defect (LAD), which do not express CR3 )hages; uptake (20) (Table I) . sident macrotreated macroptake through ture in this CR3 analogue on C. albicans might facilitate phagocytosis through binding to some mannose-bearing structure on the surface ofmacrophages. We therefore preincubated C. albicans (5 X 106/ml) with Man-BSA (64 ,gg mannose/ml) for 25 min at 370C, centrifuged and washed twice with buffer, and studied phagocytosis. There was no inhibition ofuptake by this treatment (49±12 and 44±11% phagocytosis of Man-BSAtreated and untreated Candida, respectively; 30-min incubation; mean±SEM, n = 5).
Effect ofIFN--y on the binding and uptake of'25I-Man-BSA by macrophages. Experiments were performed at 00C to estimate the effect of incubation with IFN-y for 48 h on the number and affinity of MMR. The amount of '25I-Man-BSA ligand bound to macrophages decreased by 79±19% (n = 5) in the IFN-y-treated cells without changes of the affinity: Kd was 3-5 x 10-8 M for both untreated cells and cells treated with 100 U/ml IFN-y (n = 5), suggesting that the decrease in ligand binding reflects a decrease in receptor density rather than binding affinity.
As shown in Table II , treatment with IFN-'y resulted in a concentration-dependent decrease in the capacity of macrophages to pinocytose '25I-Man-BSA at 37°C. Inhibition at 100 U/ml IFN-'y was 83±2%. Kinetics of the pinocytic uptake of '251-Man-BSA were investigated in macrophages treated with 100 U/ml IFN-'y (Fig. 4) . K~ptk, the concentration of ligand at which uptake is half-maximal, was estimated graphically using double reciprocal plots. Treatment with IFN-'y decreased the V", of '251I-Man-BSA uptake by 73±6% (n = 3) without altering the Kupk,, of pinocytosis (3-4 X 10-8 M for both untreated and IFN-y-treated cells). These findings suggest that the decreased pinocytic rate of 1251I-Man-BSA by IFN-y-treated macrophages also reflects a decrease in receptor number rather than affinity. Shepherd Candida-induced mobilization off Ca2" j. 0  170  260  124  10  119  183  105  50  76  62  100  24  43  26  500  1 1  17  14 Macrophages from three donors were incubated for 48 h with the concentrations of IFN--y shown. These cells were washed and incubated for 10 min at 370C with 20 Ag/ml '25I-Man-BSA. Specific uptake is shown (average ofduplicates). Nonspecific uptake was always < 15% oftotal uptake as assessed in the presence of 2 mg/ml mannan. 
Discussion
A plasma membrane receptor for ligands with terminal mannose residues, the MMR, has been defined on human and rodent macrophages (4, (8) (9) (10) (11) (12) (13) 31 ) . A similar receptor has been identified on human retinal pigmented epithelium (32) . These mannose receptors can mediate endocytic clearance of glycoproteins, including enzymes from neutrophils, rod outer segments, and tissue-type plasminogen activator (32) (33) (34) ; and the MMR can mediate phagocytosis of microorganisms (4, (11) (12) (13) (14) (15) . Expression ofsurface MMR can be downregulated during macrophage activation (16) (17) (18) and upregulated by corticosteroids, prostaglandin E, and IL-4 (34) (35) (36) . The capacity of the MMR to clear mannose-containing proteins has been used to target replacement of the deficient enzyme in Gaucher's disease (37 IFN-y has been reported to increase both the number and function of receptors for IgG (FcR) on human mononuclear phagocytes (38, 39) . In contrast, the number of macrophage receptors for C3b (CR1 ) and iC3b (CR3) appeared unaffected by IFN-y treatment, but binding and uptake through these (28) . It seems likely that the Ca 2+ response in IFN-y-treated macrophages observed in this study plays a part in the increased°2 production and killing of Candida exhibited by these cells. activated macrophages. This conclusion raises the possibility that IFN-y administration might have therapeutic use in candidal infection by enhancing the capacity of tissue macrophages to increase both opsonin-dependent and opsonin-independent uptake and killing of this increasingly serious pathogen.
